Can Telangana Attract $25 Billion Investment in Life Sciences by 2030?
Click to start listening
Synopsis
In an ambitious move, Telangana sets a target of attracting $25 billion in life sciences investments by 2030. With a strategic roadmap and innovative initiatives, the state aims to become a leader in global life sciences, creating jobs and enhancing research capabilities.
Key Takeaways
- Investment target of $25 billion in life sciences by 2030.
- Creation of 500,000 jobs in the sector.
- Focus on sustainable manufacturing and high-value R&D.
- Introduction of the Life Sciences Innovation Fund.
- Hyderabad as a global hub for vaccine production.
Hyderabad, Jan 21 (NationPress) The government of Telangana is aiming to secure $25 billion in investments for the life sciences sector over the next five years.
During the World Economic Forum in Davos, officials presented the Telangana Next-Gen Life Sciences Policy 2026–2030, outlining a strategy to rank Telangana among the world’s top five life sciences hubs by 2030.
Chief Minister A. Revanth Reddy, who is heading a team of ministers and officials at the WEF annual gathering, introduced the new policy.
According to Industry Minister Sridhar Babu, the plan aims for $25 billion in investments and the generation of 500,000 new jobs, emphasizing high-value research and development, advanced biologics, therapies, and sustainable manufacturing practices.
Major initiatives under this policy include the Green Pharma City, flagship Pharma Villages, and 1Bio, an innovative growth-phase center along with a biopharma scale-up manufacturing facility.
The state government also plans to launch a dedicated Life Sciences Innovation Fund with a potential scale of ₹1,000 crore ($111 million).
“Hyderabad is already home to the World Economic Forum’s Fourth Industrial Revolution (C4IR) Network and the first center focused on healthcare and life sciences globally, positioning Telangana to spearhead the upcoming wave of international life sciences innovation. We are forming a future-ready ecosystem that is science-led, sustainable, and competitive on a global scale,” remarked the minister.
By capitalizing on its strengths in pharmaceutical manufacturing, vaccine production, and R&D, while strategically branching into emerging sectors like biologics, precision medicine, and biomanufacturing, Telangana is set to revolutionize healthcare and life sciences innovation, according to the policy document.
Currently, Telangana contributes 40% of India’s pharmaceutical production and is the only place worldwide with over 250 USFDA-approved manufacturing sites.
It has also earned its title as the vaccine capital of the world, significantly contributing to the fight against the COVID-19 pandemic, with a total vaccine production capacity of around 14 billion doses, reinforcing its position as a global vaccine hub.
Additionally, the region is becoming a leader in producing medical devices and diagnostic equipment, supported by a thriving ecosystem.
Point of View
The efforts by Telangana to enhance its life sciences sector reflect a significant commitment to innovation and job creation. This initiative not only positions Telangana as a competitive player on the global stage but also contributes positively to India’s overall economic development in the health sector.
NationPress
21/01/2026
Frequently Asked Questions
What is the investment target for Telangana's life sciences sector by 2030?
The Telangana government is targeting $25 billion in investments in the life sciences sector by 2030.
What are the key initiatives included in the new policy?
Key initiatives include the Green Pharma City, flagship Pharma Villages, and 1Bio growth-phase center.
How many new jobs are expected to be created?
The policy aims to create approximately 500,000 new jobs in the life sciences sector.
What is the significance of Hyderabad in the life sciences field?
Hyderabad is home to the World Economic Forum’s Fourth Industrial Revolution Network and is recognized for its substantial contributions to vaccine production.
How does Telangana contribute to India's pharmaceutical production?
Telangana currently contributes 40% of India's pharmaceutical production.
